, Tracking Stock Market Picks
Enter Symbol:
Idenix Pharmaceuticals, Inc. (IDIX) [hlAlert]

down 85.37 %

Idenix Pharmaceuticals, Inc. (IDIX) upgraded to Outperform by Robert W. Baird

Posted on: Monday,  Jun 9, 2014  12:00 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) on 06/09/2014. Previously Robert W. Baird rated Underperform Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX)
on 06/21/2013., when the stock price was $3.48. Since then, Idenix Pharmaceuticals, Inc. has gained 583.62% as of 06/09/2014's recent price of $23.79.
If you would have followed the previous Robert W. Baird's recommendation on IDIX, you would have lost 85.37% of your investment in 353 days.

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/9/2014 12:00 AM Buy
as of 10/17/2014
1 Week   
1 Month   
3 Months up  1.91 %
1 YTD down  -294.84 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/21/2013 8:25 AM Sell
2/12/2013 8:25 AM Hold
4.89 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy